C-C motif chemokine receptor 3 (CCR3) is specifically expressed in choroidal neovascular endothelial cells in humans with AMD and is believed to be a therapeutic target for AMD [270,271,272]. This evidence concerns the gene CCR3 and age-related macular degeneration.